CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
116.5
1.84%
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 15:25

Mon - Fri: 07:00 - 15:25

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 2.0
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.02194 %
Charges from full value of position ($-4.17)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02194%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000282 %
Charges from full value of position ($-0.05)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000282%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 5%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

Biogaia AB ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 114.4
Open* 116.7
1-Year Change* 26.85%
Day's Range* 116.2 - 117.3
52 wk Range 87.95-119.40
Average Volume (10 days) 73.70K
Average Volume (3 months) 2.10M
Market Cap 10.31B
P/E Ratio 24.47
Shares Outstanding 100.98M
Revenue 1.27B
EPS 4.33
Dividend (Yield %) 2.73585
Beta 0.57
Next Earnings Date Feb 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 22, 2024 114.4 -4.4 -3.70% 118.8 119.1 114.4
Apr 19, 2024 117.3 -0.8 -0.68% 118.1 119.1 117.3
Apr 18, 2024 118.1 0.8 0.68% 117.3 119.4 117.3
Apr 17, 2024 119.0 0.2 0.17% 118.8 119.5 117.4
Apr 16, 2024 118.1 1.3 1.11% 116.8 118.2 116.3
Apr 15, 2024 117.7 1.8 1.55% 115.9 117.7 114.6
Apr 12, 2024 114.6 0.1 0.09% 114.5 115.8 112.8
Apr 11, 2024 114.5 0.2 0.17% 114.3 115.0 113.3
Apr 10, 2024 114.7 0.0 0.00% 114.7 115.8 114.1
Apr 9, 2024 114.9 0.9 0.79% 114.0 116.3 114.0
Apr 8, 2024 115.0 -0.5 -0.43% 115.5 116.1 113.3
Apr 5, 2024 115.5 1.4 1.23% 114.1 116.9 113.2
Apr 4, 2024 114.9 -2.9 -2.46% 117.8 117.8 113.7
Apr 3, 2024 115.8 -7.4 -6.01% 123.2 123.2 113.0
Apr 2, 2024 124.0 0.2 0.16% 123.8 125.1 119.6
Mar 28, 2024 124.1 -5.6 -4.32% 129.7 130.3 120.7
Mar 27, 2024 133.1 0.2 0.15% 132.9 134.7 131.4
Mar 26, 2024 132.2 1.3 0.99% 130.9 132.9 130.8
Mar 25, 2024 132.3 2.9 2.24% 129.4 132.8 129.4
Mar 22, 2024 128.9 0.9 0.70% 128.0 129.4 126.8

Biogaia B Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

06:00

Country

SE

Event

Q1 2024 Biogaia AB Interim Management Release
Q1 2024 Biogaia AB Interim Management Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

SE

Event

Biogaia AB Annual Shareholders Meeting
Biogaia AB Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 8, 2024

Time (UTC)

12:00

Country

SE

Event

Biogaia AB
Biogaia AB

Forecast

-

Previous

-

Time (UTC)

12:00

Country

SE

Event

Biogaia AB
Biogaia AB

Forecast

-

Previous

-
Sunday, July 7, 2024

Time (UTC)

06:00

Country

SE

Event

Q2 2024 Biogaia AB Earnings Release
Q2 2024 Biogaia AB Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1103.96 785.11 747.077 768.347 741.87
Revenue 1103.96 785.11 747.077 768.347 741.87
Cost of Revenue, Total 302.028 202.161 200.159 204.349 185.956
Gross Profit 801.929 582.949 546.918 563.998 555.914
Total Operating Expense 742.498 531.373 518.927 525.836 464.511
Selling/General/Admin. Expenses, Total 358.26 233.221 196.289 207.058 179.783
Research & Development 103.977 102.865 102.84 103.164 98.776
Depreciation / Amortization 5.184 4.364 3.296 3.765 1.945
Interest Expense (Income) - Net Operating -26.792 -11.506 0 -6.504
Operating Income 361.459 253.737 228.15 242.511 277.359
Interest Income (Expense), Net Non-Operating 86.154 -1.025 -0.567 -0.252 0.641
Other, Net -0.405
Net Income Before Taxes 447.613 252.712 227.583 242.259 277.595
Net Income After Taxes 373.773 196.273 179.73 187.258 214.233
Minority Interest 0 0 0 0.089 0.657
Net Income Before Extra. Items 373.773 196.273 179.73 187.347 214.89
Total Extraordinary Items
Net Income 373.773 196.273 179.73 187.347 214.89
Income Available to Common Excl. Extra. Items 373.773 196.273 179.73 187.347 214.89
Income Available to Common Incl. Extra. Items 373.773 196.273 179.73 187.347 214.89
Diluted Net Income 373.773 196.273 179.73 187.347 214.89
Diluted Weighted Average Shares 100.982 100.963 89.2403 86.68 86.68
Diluted EPS Excluding Extraordinary Items 3.70138 1.944 2.014 2.16136 2.47912
Dividends per Share - Common Stock Primary Issue 2.9 1.452 1.364 1.6 2
Diluted Normalized EPS 3.74232 2.07652 2.014 2.16136 2.47912
Other Operating Expenses, Total 0 0.366 16.343 7.5 4.555
Unusual Expense (Income) -0.159 -0.098
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 317.694 315.217 365.821 274.283 257.733
Revenue 317.694 315.217 365.821 274.283 257.733
Cost of Revenue, Total 81.847 88.779 103.309 66.291 71.952
Gross Profit 235.847 226.438 262.512 207.992 185.781
Total Operating Expense 198.156 220.18 217.823 203.157 163.998
Selling/General/Admin. Expenses, Total 96.002 101.045 97.887 101.961 84.578
Research & Development 20.63 38.816 18.684 31.431 22.557
Other Operating Expenses, Total -0.323 -8.46 -2.057 3.474 -15.089
Operating Income 119.538 95.037 147.998 71.126 93.735
Interest Income (Expense), Net Non-Operating 8.484 7.023 2.563 81.323 5.066
Net Income Before Taxes 128.022 102.06 150.561 152.449 98.801
Net Income After Taxes 101.501 80.547 115.945 139.428 79.503
Minority Interest 0 0 0 0 0
Net Income Before Extra. Items 101.501 80.547 115.945 139.428 79.503
Net Income 101.501 80.547 115.945 139.428 79.503
Income Available to Common Excl. Extra. Items 101.501 80.547 115.945 139.428 79.503
Income Available to Common Incl. Extra. Items 101.501 80.547 115.945 139.428 79.503
Diluted Net Income 101.501 80.547 115.945 139.428 79.503
Diluted Weighted Average Shares 100.982 100.982 100.982 100.982 100.982
Diluted EPS Excluding Extraordinary Items 1.00514 0.79764 1.14817 1.38072 0.7873
Dividends per Share - Common Stock Primary Issue 0 0 0 2.9 0
Diluted Normalized EPS 1.00514 0.80747 1.14817 1.39612 0.7873
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1797.48 1752.08 1689.58 452.438 494.415
Cash and Short Term Investments 1488.37 1484.68 1467.88 218.814 289.794
Cash & Equivalents 1488.37 1484.68 1467.88 213.831 284.962
Short Term Investments 0 4.983 4.832
Total Receivables, Net 149.455 148.53 143.196 156.316 154.819
Accounts Receivable - Trade, Net 131.054 128.152 101.658 129.763 142.009
Total Inventory 142.838 102.737 72.277 68.445 44.213
Prepaid Expenses 1.872 0 1.735 1.731 1.477
Other Current Assets, Total 14.95 16.13 4.486 7.132 4.112
Total Assets 2213.97 2128.05 1913.28 665.9 659.973
Property/Plant/Equipment, Total - Net 157.725 153.635 162.765 149.042 105.935
Property/Plant/Equipment, Total - Gross 301.359 275.996 256.218 218.949 166.773
Accumulated Depreciation, Total -143.634 -122.361 -93.453 -69.909 -60.84
Intangibles, Net 46.075 48.086 50.322 52.558 45.85
Long Term Investments 25.843 22.272 0.039 0.044 0.043
Other Long Term Assets, Total 15.325 2.757 5.279 6.518 8.43
Total Current Liabilities 164.991 126.954 135.062 124.8 145.173
Accounts Payable 32.05 42.313 48.046 28.491 34.009
Accrued Expenses 77.945 56.399 48.723 53.913 57.349
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 43.896 19.342 30.093 34.83 53.815
Total Liabilities 241.55 250.689 167.039 158.028 154.991
Total Long Term Debt 0 10.4 20.7 17.254 0
Deferred Income Tax 12.552 14.24 11.312 10.339 6.679
Minority Interest 0.002 0.002 0.002 0.002 3.139
Total Equity 1972.42 1877.36 1746.24 507.872 504.982
Common Stock 20.196 20.196 20.196 17.336 17.336
Additional Paid-In Capital 1153.79 1154.01 1149.48 21.831 43.662
Retained Earnings (Accumulated Deficit) 798.426 703.161 576.564 468.705 443.984
Total Liabilities & Shareholders’ Equity 2213.97 2128.05 1913.28 665.9 659.973
Total Common Shares Outstanding 100.982 98.0196 98.0196 83.7196 83.7196
Goodwill, Net 171.517 149.227 5.3 5.3 5.3
Current Port. of LT Debt/Capital Leases 11.1 8.9 8.2 7.566
Capital Lease Obligations 10.4 20.7 17.254
Other Liabilities, Total 64.005 99.093 -0.037 5.633
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1834.53 1718.72 1922.49 1797.48 1728.3
Cash and Short Term Investments 1452.53 1369.57 1580.82 1488.37 1402.41
Cash & Equivalents 1452.53 1369.57 1580.82 1488.37 1402.41
Other Current Assets, Total 382.002 349.159 341.664 16.841 325.89
Total Assets 2304.25 2157.08 2324 2213.97 2161.37
Property/Plant/Equipment, Total - Net 208.776 178.091 152.293 157.725 163.321
Goodwill, Net 177.906 178.059 170.084 171.517 182.343
Intangibles, Net 46.172 46.154 46.128 46.075 46.409
Long Term Investments 28.065 28.065 25.842 25.843 25.845
Other Long Term Assets, Total 8.804 7.982 7.17 15.325 15.154
Total Current Liabilities 217.488 217.764 186.275 164.991 173.367
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 217.488 217.764 186.275 43.896 173.367
Total Liabilities 318.982 273.271 237.137 241.55 312.53
Total Long Term Debt 0 0 0 0 0
Deferred Income Tax 13.274 13.29 12.532 12.552 14.166
Minority Interest 0.002 0.002 0.002 0.002 0.002
Other Liabilities, Total 88.218 42.215 38.328 64.005 124.995
Total Equity 1985.27 1883.81 2086.87 1972.42 1848.84
Other Equity, Total 1985.27 1883.81 2086.87 1972.42 1848.84
Total Liabilities & Shareholders’ Equity 2304.25 2157.08 2324 2213.97 2161.37
Total Common Shares Outstanding 100.982 100.982 100.982 100.982 100.982
Total Receivables, Net 149.436
Accounts Receivable - Trade, Net 130.703
Total Inventory 142.838
Accounts Payable 32.05
Accrued Expenses 77.945
Current Port. of LT Debt/Capital Leases 11.1
Capital Lease Obligations
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 361.459 253.737 228.15 242.511 277.359
Cash From Operating Activities 318.943 221.875 221.256 147.855 183.12
Cash From Operating Activities 23.89 27.241 20.53 15.593 7.546
Non-Cash Items -9.103 0.047 -3.709 3.075 0.591
Cash Taxes Paid 54.91 55.934 72.092 72.292 52.408
Cash Interest Paid 0.694 0.401
Changes in Working Capital -57.303 -59.15 -23.715 -113.324 -102.376
Cash From Investing Activities -18.141 -126.967 -16.075 -39.024 -47.301
Capital Expenditures -17.916 -6.379 -16.075 -39.024 -13.454
Other Investing Cash Flow Items, Total -0.225 -120.588 0 -33.847
Cash From Financing Activities -313.588 -81.846 1051.4 -181.09 -158.728
Total Cash Dividends Paid -301.331 -68.87 -65.012 -173.365 -156.028
Issuance (Retirement) of Stock, Net -0.214 4.525 1126.84
Foreign Exchange Effects 16.472 3.735 -2.525 1.128 2.015
Net Change in Cash 3.686 16.797 1254.05 -71.131 -20.894
Financing Cash Flow Items -2.9 -2.8 -2.8 -3.2 -2.7
Issuance (Retirement) of Debt, Net -9.143 -14.701 -7.632 -4.525
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 147.998 361.459 290.333 196.598 95.295
Cash From Operating Activities 98.434 318.943 227.624 180.355 93.065
Cash From Operating Activities 6.519 23.89 17.25 12.131 6.049
Non-Cash Items -0.044 -9.103 -12.048 -12.63 -1.136
Cash Taxes Paid 34.995 54.91 56.67 35.943 17.512
Changes in Working Capital -56.039 -57.303 -67.911 -15.744 -7.143
Cash From Investing Activities -1.332 -18.141 -18.433 -13.896 -5.081
Capital Expenditures -1.279 -17.916 -18.433 -13.896 -5.081
Cash From Financing Activities -3.36 -313.588 -310.977 -305.541 -2.211
Financing Cash Flow Items 0 -2.9 -2.9 0 0
Total Cash Dividends Paid 0 -301.331 -301.331 -301.331 0
Issuance (Retirement) of Stock, Net -0.417 -0.214 -0.206 -0.206 -0.206
Issuance (Retirement) of Debt, Net -2.943 -9.143 -6.54 -4.004 -2.005
Foreign Exchange Effects -1.286 16.472 19.515 10.746 1.24
Net Change in Cash 92.456 3.686 -82.271 -128.336 87.013
Other Investing Cash Flow Items, Total -0.053 -0.225 0 0 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biogaia Company profile

About BioGaia AB

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, BioGaia AB revenues increased 5% to SEK785.1M. Net income increased 9% to SEK196.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other operating expenses/operating incom decrease from SEK17.4M (expense) to SEK11.2M (income). Dividend per share increased from SEK6.82 to SEK7.26.

Industry: Biopharmaceuticals

Kungsbroplan 3
STOCKHOLM
STOCKHOLM 112 27
SE

Income Statement

  • Annual
  • Quarterly

News

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

People also watch

BTC/USD

66,118.45 Price
-0.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

ETH/USD

3,183.07 Price
-0.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.55 Price
-3.540% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

17,256.50 Price
+0.280% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading